Long-term efficacy and safety of peptide receptor radionuclide therapy in Japanese patients with unresectable neuroendocrine tumor: extension of the Japanese phase I and phase I/II study

Authors

Institutions

Publication Details

Journal
Annals of Nuclear Medicine
Published
2026-02-12
DOI
https://doi.org/10.1007/s12149-026-02169-1
Primary Topic
Neuroendocrine Tumor Research Advances
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Long-term efficacy and safety of peptide receptor radionuclide therapy in Japanese patients with unresectable neuroendocrine tumor: extension of the Japanese phase I and phase I/II study

Keiichi Akahoshi, Daisuke Ban Daisuke Ban, Hiroaki Ono, Atsushi Kudo et al.
Annals of Nuclear Medicine
Neuroendocrine Tumor Research Advances
article

Long-term efficacy and safety of peptide receptor radionuclide therapy in Japanese patients with unresectable neuroendocrine tumor: extension of the Japanese phase I and phase I/II study

Keiichi Akahoshi, Daisuke Ban Daisuke Ban, Hiroaki Ono, Atsushi Kudo, Noritoshi Kobayashi, Yasushi Ichikawa, Naoki Okubo
article en

Abstract

No abstract available for this paper.
Annals of Nuclear Medicine
Institute of Science Tokyo (JP), Yokohama City University (JP)
Good health and well-being
Openalex Percentile: Top 57%
Neuroendocrine Tumor Research Advances
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.